Why Analysts See the GSK Story Shifting Amid Digital Gains and Strategic Investments
GSK stock has seen a modest increase in its Fair Value Estimate, climbing from $16.51 to $16.63 per share while...
GSK
2025 Dermatology Treatment and Care Market Analysis Report with Impact Analysis of US Tariffs Featuring Novartis, Pfizer, Amgen, GSK, F. Hoffmann-La Roche, J&J, AbbVie, Merck, Bayer, Sanofi
Company Logo The global dermatology market is driven by increasing skin disorder prevalence, aging demographics, and technological innovations like teledermatology...
